Fatty Liver Disease (FLD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population
Conditions: Metabolic Dysfunction Associated Steatotic Liver Disease; Non-Alcoholic Fatty Liver Disease (NAFLD) Interventions: Diagnostic Test: Velacur; Diagnostic Test: MRI; Diagnostic Test: Blood sample collection for biomarkers; Diagnostic Test: Liver biopsy Sponsors: Emory University; Sonic Incytes Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials

Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease
Conditions: Type 2 Diabetes; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Henagliflozin; Other: Background medication Sponsors: Sir Run Run Shaw Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials

Feasibility of Immersive Virtual Reality Dietician Program in Metabolic-dysfunction Associated Steatotic Liver Disease
Conditions: Fatty Liver, Nonalcoholic; Weight Loss; Virtual Reality; Implementation Science Interventions: Behavioral: In-person dietary weight loss counseling; Behavioral: Virtual reality dietary weight loss counseling Sponsors: Milton S. Hershey Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
Conditions: Cardiovascular Diseases; Metabolic Syndrome; Non-Alcoholic Fatty Liver Disease Interventions: Behavioral: Digital wearable and AI-human symbiotic lifestyle intervention Sponsors: National University Hospital, Singapore; National University of Singapore Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials

Liver Steatosis in Pediatric CD Patients
Conditions: Celiac Disease in Children; Non-Alcoholic Fatty Liver Disease Interventions: Behavioral: Gluten-free diet Sponsors: University of Palermo; ARNAS Civico Di Cristina Benfratelli Hospital; Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials

Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter
Conditions: Fatty Liver Interventions: Behavioral: Lifestyle modification programme Sponsors: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials

A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver
Conditions: Efficacy and Safety Interventions: Drug: Huazhi Rougan granule Sponsors: Shandong New Time Pharmaceutical Co., LTD Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials

A Phase IV Study of Huazhi Rougan Granule
Conditions: A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver Interventions: Drug: Huazhi Rougan Granule Placebo granule Sponsors: Shandong New Time Pharmaceutical Co., LTD Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials

Short Term Outcome of Metabolic Associated Fatty Liver Disease (MAFLD) in Patients Undergoing Bariatric Surgery
Conditions: Metabolic Associated Fatty Liver Disease; Bariatric Surgery Candidate Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials

Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease; Non Alcoholic Fatty Liver; Non Alcoholic Steatohepatitis; NAFLD; NASH Interventions: Drug: Hyperpolarized (HP) 13C; Drug: Hyperpolarized 13C-Urea; Procedure: Magnetic Resonance Imaging; Procedure: Saline Flush Sponsors: Michael Ohliger, MD PhD; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials

The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Other: Ginseng oligopeptide (Ginseng extract ）; Other: Maltodextrin Sponsors: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials

Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease
Conditions: Nonalcoholic Fatty Liver Disease Sponsors: Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Conditions: NASH/MASH; NAFLD/MASLD Interventions: Drug: Efruxifermin; Drug: Placebo Sponsors: Akero Therapeutics, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GN
Conditions: Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development Sponsors: Assiut University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials

Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: GODEX; Drug: Placebo Sponsors: Yoon Jun Kim; Celltrion Pharm, Inc. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials